These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1112 related items for PubMed ID: 16703499

  • 1. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [Abstract] [Full Text] [Related]

  • 2. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [Abstract] [Full Text] [Related]

  • 3. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F, Block W, Flacke S, Lamerichs R, Schüller H, Urbach H, Keller E, Schild HH.
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [Abstract] [Full Text] [Related]

  • 4. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):20-31. PubMed ID: 15850898
    [Abstract] [Full Text] [Related]

  • 6. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS, Li CF, Liu H, Zhen JH, Feng DC.
    Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):151-8. PubMed ID: 17289287
    [Abstract] [Full Text] [Related]

  • 7. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.
    Eur J Radiol; 2011 Nov 01; 80(2):462-70. PubMed ID: 20708868
    [Abstract] [Full Text] [Related]

  • 8. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W.
    Acad Radiol; 2005 Jan 01; 12(1):51-7. PubMed ID: 15691725
    [Abstract] [Full Text] [Related]

  • 9. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
    Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):773-81. PubMed ID: 18262090
    [Abstract] [Full Text] [Related]

  • 10. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE, Carlos RC, Smith EA, Frechtling D, George B, Maly P, Sundgren PC.
    Acad Radiol; 2011 Sep 01; 18(9):1101-8. PubMed ID: 21820634
    [Abstract] [Full Text] [Related]

  • 11. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP, Henze M, Plathow C, Bachert P, Kauczor HU, Schlemmer HP.
    Rofo; 2004 Aug 01; 176(8):1114-21. PubMed ID: 15346287
    [Abstract] [Full Text] [Related]

  • 12. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
    Hourani R, Horská A, Albayram S, Brant LJ, Melhem E, Cohen KJ, Burger PC, Weingart JD, Carson B, Wharam MD, Barker PB.
    J Magn Reson Imaging; 2006 Feb 01; 23(2):99-107. PubMed ID: 16374884
    [Abstract] [Full Text] [Related]

  • 13. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P, Sundgren PC, Maly P, Hassan DG, Nan B, Rohrer S, Junck L.
    AJR Am J Roentgenol; 2005 Dec 01; 185(6):1471-6. PubMed ID: 16304000
    [Abstract] [Full Text] [Related]

  • 14. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J, Wang AM, Shetty A, Maitz AH, Yan D, Doyle D, Richey K, Park S, Pieper DR, Chen PY, Grills IS.
    Magn Reson Imaging; 2011 Sep 01; 29(7):993-1001. PubMed ID: 21571478
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stadlbauer A, Buchfelder M, Doelken MT, Hammen T, Ganslandt O.
    Cent Eur Neurosurg; 2011 May 01; 72(2):63-9. PubMed ID: 20635312
    [Abstract] [Full Text] [Related]

  • 16. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):126-37. PubMed ID: 15093908
    [Abstract] [Full Text] [Related]

  • 17. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
    Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM.
    Cancer; 2004 Mar 15; 100(6):1246-56. PubMed ID: 15022293
    [Abstract] [Full Text] [Related]

  • 18. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ.
    NMR Biomed; 2004 Feb 15; 17(1):10-20. PubMed ID: 15011246
    [Abstract] [Full Text] [Related]

  • 19. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    Isobe T, Akutsu H, Yamamoto T, Shiigai M, Masumoto T, Nakai K, Takano S, Anno I, Matsumura A.
    No Shinkei Geka; 2011 May 15; 39(5):485-90. PubMed ID: 21512199
    [Abstract] [Full Text] [Related]

  • 20. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
    Blamek S, Larysz D, Ficek K, Sokół M, Miszczyk L, Tarnawski R.
    Acta Neurochir Suppl; 2010 May 15; 106():183-6. PubMed ID: 19812945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.